These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 28688279)

  • 1. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
    Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA
    Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel triazoles and a tetrazole of escitalopram as cholinesterase inhibitors.
    Mehr-un-Nisa ; Munawar MA; Chattha FA; Kousar S; Munir J; Ismail T; Ashraf M; Khan MA
    Bioorg Med Chem; 2015 Sep; 23(17):6014-24. PubMed ID: 26189031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.
    Razavi SF; Khoobi M; Nadri H; Sakhteman A; Moradi A; Emami S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2013 Jun; 64():252-9. PubMed ID: 23644208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines.
    Kumar RS; Almansour AI; Arumugam N; Althomili DMQ; Altaf M; Basiri A; D K; Sai Manohar T; S V
    Bioorg Chem; 2018 Apr; 77():263-268. PubMed ID: 29421701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
    Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
    Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
    Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M
    Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives.
    Alipour M; Khoobi M; Moradi A; Nadri H; Homayouni Moghadam F; Emami S; Hasanpour Z; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Jul; 82():536-44. PubMed ID: 24941128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.
    Vafadarnejad F; Mahdavi M; Karimpour-Razkenari E; Edraki N; Sameem B; Khanavi M; Saeedi M; Akbarzadeh T
    Bioorg Chem; 2018 Apr; 77():311-319. PubMed ID: 29421707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro evaluation of novel rhodanine derivatives as potential cholinesterase inhibitors.
    Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
    Bioorg Chem; 2016 Oct; 68():23-9. PubMed ID: 27428597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and evaluation of difunctionalized 4-hydroxybenzaldehyde derivatives as novel cholinesterase inhibitors.
    Yu L; Cao R; Yi W; Yan Q; Chen Z; Ma L; Song H
    Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1216-20. PubMed ID: 20823602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
    Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors.
    Gao CZ; Dong W; Cui ZW; Yuan Q; Hu XM; Wu QM; Han X; Xu Y; Min ZL
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):150-162. PubMed ID: 30427217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkynyl and β-ketophosphonates: Selective and potent butyrylcholinesterase inhibitors.
    Cavallaro V; Moglie YF; Murray AP; Radivoy GE
    Bioorg Chem; 2018 Apr; 77():420-428. PubMed ID: 29427857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation and docking studies of 2,3-dihydroquinazolin-4(1H)-one derivatives as inhibitors of cholinesterases.
    Sarfraz M; Sultana N; Rashid U; Akram MS; Sadiq A; Tariq MI
    Bioorg Chem; 2017 Feb; 70():237-244. PubMed ID: 28126287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.
    Wu J; Pistolozzi M; Liu S; Tan W
    Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
    Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
    Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies.
    Cavdar H; Senturk M; Guney M; Durdagi S; Kayik G; Supuran CT; Ekinci D
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):429-437. PubMed ID: 30734597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Efficient Synthesis of bi-Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer's Disease.
    Rehman TU; Khan IU; Ashraf M; Tarazi H; Riaz S; Yar M
    Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28220522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.